CONSULTING AGREEMENT

1.    Parties.

1.1. This  Consulting  Agreement  (this  "Agreement")  is made and entered  into
     effective as of November 14, 2002, by and between  BioCurex  (ticker:BOCX),
     (the  "Company"),  whose  address  is:  Suite  201,  30211  Avenida  de las
     Banderas,  Rancho Santa  Margarita,  CA 92688,  U.S.A,  and, Dr, Ardao (the
     "Consultant"),  whose address is Baltasar Vargas 1273,  Montevideo Uruguay,
     CP 11300.

 2. Recitals.

2.1  This  Agreement  is  made  with  reference  to  the  following   facts  and
     circumstances.

(a)  The Company  wishes to engage the services of the  Consultant to advise and
     consult with the Company on certain scientific matters as set forth in this
     Agreement.

(b)  The Consultant is willing to accept such engagement, on the terms set forth
     in this Agreement.

2.2  In  consideration  of  the  premises,  and  for  other  good  and  valuable
     consideration, the receipt of which is hereby acknowledged, the Company and
     the Consultant agree as follows.


3. Engagement.

3.1  The  Company  hereby  engages  the  services  of  the  Consultant,   as  an
     independent contractor for a term of nine and one half months, beginning on
     November 15, 2002, and, ending on December,  31, 2003 (the "Term"), and the
     Consultant  hereby accepts such  engagement,  for the purposes set forth in
     section 3.2. below.

3.2  The scope of the services to be rendered by the  Consultant  to the Company
     are and are limited to the following:

     (a)  The  Consultant  shall advise and consult with the Company's  board of
          directors and executive  officers  regarding the Company's  scientific
          program including the development of the Histo-RECAF  diagnostic kits.





     (b)  Subject to executive, and board approval, the Consultant shall seek to
          recommend new scientific  board members,  to assist with the execution
          of the companies business plan;

     (c)  The  Consultant  shall  devote  such  time  to this  engagement  as is
          reasonably necessary, but the Consultant need not devote his full time
          or  attention  to the  engagement.  The  Company  recognizes  that the
          Consultant has numerous  engagements,  and that this engagement is not
          exclusive.


4.    The Consultant's Fees and Expenses.

4.1  The Company  shall pay the  Consultant,  any and all expenses  incurred by,
     and, at the  discretion  of the  Consultant,  on behalf of the Company,  in
     accordance  with section 3.2 of this  agreement.  As a fee for his services
     under this  Agreement  (the  "Consulting  Fee") an advisory fee  ("Advisory
     Fee") equal to 500,000 shares issued under rule S-8, as set out in appendix
     "A"  (attached).  The  Company  shall  comply with all  securities  laws in
     connection  with  the  issuance  of  such  shares  and  make  all  required
     regulatory filings.

5. Miscellaneous

5.1   Relationship.  The  relationship  between the Company and the Consultant
            created  by this  Agreement  is that of  independent  contractors.
            The Consultant is not, by virtue of this Agreement,  and shall not
            for any purpose be deemed to be hereunder,  an officer,  employee,
            agent or  affiliate  of the  Company.  The services to be rendered
            by the  Consultant  pursuant to this  Agreement do not include the
            services or activities of an  "investment  adviser",  as that term
            is defined by U.S./ Canadian,  federal, state, or, provincial laws
            and, in performing  services under this Agreement,  the Consultant
            shall not be deemed to be an "investment adviser" under such laws.

5.2  Indemnity.  The Company  hereby agrees to defend,  indemnify,  and hold the
     Consultant  harmless  from  and  against  any  and  all  claims,   damages,
     judgements,  penalties,  costs, and expenses  (including  attorney fees and
     court costs now or hereafter  arising from the  enforcement of this clause)
     arising  directly or indirectly from the activities of the Consultant under
     this  Agreement,  or  from  the  Activities  of the  Company  or any of its
     shareholders, officers, directors, employees, agents or affiliates, whether
     such claims are asserted by any  governmental  agency or any other  person.
     This indemnity shall survive termination of this Agreement.

5.3  Governing  Law.  This  Agreement  and the Note  shall be  governed  by, and
     construed in accordance with, the laws of the province of British Columbia.
     The Supreme Court of British Columbia shall have exclusive jurisdiction for
     any action arising out of, or, related to this Agreement.




     IN WITNESS WHEREOF,  the parties have executed this Agreement,  effective
     as of the date first above written.

      The Company:                              The Consultant

      BioCurex  Inc.,

      By /s/ Dr. Ricardo Moro                  By /s/ Dr. Gonzalo Ardao
         ---------------------                    -----------------------

      Name: Dr. Ricardo Moro                    Name: Dr.  Gonzalo Ardao

      Title:President                           Title:Consultant

      Date signed: Nov 3, 2002                  Date signed:____________